Neola Medical AB (publ) (STO:NEOLA)

Market Cap	186.30M
Revenue (ttm)	10.39M
Net Income (ttm)	-10.06M
Shares Out	77.95M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,348
Average Volume	16,491
Open	2.550
Previous Close	2.390
Day's Range	2.390 - 2.550
52-Week Range	1.870 - 3.780
Beta	1.00
RSI	42.32
Earnings Date	Apr 9, 2025

About Neola Medical AB

Neola Medical AB (publ) develops medical technology device for continuous monitoring of the lungs of preterm born infants. The company offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NEOLA

Financial Performance

In 2024, Neola Medical AB's revenue was 10.39 million, an increase of 5.77% compared to the previous year's 9.83 million. Losses were -10.06 million, 11.7% more than in 2023.